KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Non-Current Assets (2016 - 2025)

Gilead Sciences (GILD) has disclosed Non-Current Assets for 17 consecutive years, with $40.7 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Assets rose 2.16% year-over-year to $40.7 billion, compared with a TTM value of $49.7 billion through Dec 2025, down 54.2%, and an annual FY2025 reading of $40.7 billion, up 2.16% over the prior year.
  • Non-Current Assets was $40.7 billion for Q4 2025 at Gilead Sciences, roughly flat from $40.7 billion in the prior quarter.
  • Across five years, Non-Current Assets topped out at $54.2 billion in Q1 2021 and bottomed at -$16.9 billion in Q1 2025.
  • Average Non-Current Assets over 5 years is $34.8 billion, with a median of $46.2 billion recorded in 2023.
  • The sharpest move saw Non-Current Assets soared 483.4% in 2023, then plummeted 140.0% in 2025.
  • Year by year, Non-Current Assets stood at $53.2 billion in 2021, then decreased by 8.37% to $48.7 billion in 2022, then dropped by 5.52% to $46.0 billion in 2023, then dropped by 13.51% to $39.8 billion in 2024, then rose by 2.16% to $40.7 billion in 2025.
  • Business Quant data shows Non-Current Assets for GILD at $40.7 billion in Q4 2025, $40.7 billion in Q3 2025, and -$14.7 billion in Q2 2025.